Drivers of Radioresistance in Prostate Cancer

Area of Science:

• Oncology
• Radiation Oncology
• Cancer Biology

Background:

• Prostate cancer (PCa) is a leading global cancer diagnosis.
• Radiotherapy is a primary treatment for localized PCa, often combined with other therapies.
• Tumor radioresistance limits radiotherapy effectiveness, leading to treatment failure and recurrence.

Purpose of the Study:

• To investigate the biological mechanisms underlying radioresistance in prostate cancer.
• To identify key factors contributing to treatment failure after radiotherapy for PCa.
• To provide insights for developing novel therapies to overcome PCa radioresistance.

Main Methods:

• This is a review article.
• Literature search on biological mechanisms of radioresistance in prostate cancer.
• Analysis of factors contributing to treatment failure and recurrence.

Main Results:

• Radioresistance in PCa is multifactorial.
• Key mechanisms include abnormal tumor vasculature, hypoxia, and metabolic alterations.
• Changes in gene expression and proteomic alterations also play a significant role.

Conclusions:

• Understanding PCa radioresistance mechanisms is crucial for improving treatment efficacy.
• Targeting these biological pathways may lead to more effective and sustained responses to radiotherapy.
• Further research into these mechanisms can guide the development of innovative therapeutic strategies.